Abstract
An analysis of the scientific literature has shown a significant interest of researchers around the world in the study of medicinal plant raw materials and new sources of herbal preparations of various pharmacological effects. One of such promising objects is the vyazolistnaya meadowsweet or labaznik, an unpretentious plant widely distributed on the territory of the Russian Federation. Due to its diverse chemical composition, labaznik has a wide range of properties necessary for the manufacture of various drugs with high pharmacological activity. The main group of biologically active substances of meadowsweet are phenolic compounds. The essential oil has noticeable antimicrobial and antifunginal activity. Today, being a pharmacopoeial plant in the Republic of Belarus, France and the United Kingdom, in the Russian Federation, meadowsweet does not have the appropriate regulatory documentation, which makes it difficult to use this plant as a source of medicines. In addition, the presence of a number of dietary supplements on the pharmaceutical market, which include different types of raw materials of meadowsweet, also requires the availability of appropriate regulatory documents. The pharmacological activity of different types of raw materials has been confirmed in a significant number of studies by scientists from different countries, however, the plant is still of interest for further testing, especially in the Russian Federation for the formation of regulatory documentation. In this article, the authors conducted a systematic analysis of scientific research on the pharmacological activity of various types of raw materials of the labasnik and assessed the prospects for its use in Russian pharmaceutical practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
